|
| Press Releases |
|
 |
|
| Wednesday, March 25, 2026 |
|
|
Hengrui Pharma Announces Strong 2025 Annual Results |
| On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. more info >> |
|
|
營收淨利再創新高！恒瑞醫藥2025年營收316.29億元 同比增長13.02% 淨利77.11億元 同比增長21.69% |
| 3月25日，恒瑞醫藥發佈2025年年度報告。報告期內，公司堅持「科技創新+國際化」雙輪驅動戰略，實現業績持續增長，營收和淨利均再創新高。 more info >> |
|
| Wednesday, May 28, 2025 |
|
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully |
| The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. more info >> |
|
| Saturday, November 9, 2019 |
|
|
Novaliq and Jiangsu Hengrui Medicine Announce a Collaboration for Investigational NOV03 and CyclASol in China |
| Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276), a fully integrated biopharmaceutical company based in China, announced the closing of an exclusive license agreement to develop, manufacture and commercialize the innovative, water-free drugs NOV03 and CyclASol(R) for the treatment of dry eye disease in the People's Republic of China (mainland China, Hong Kong, Macau and Taiwan). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Xunce Technology's Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?
Mar 27, 2026 19:19 HKT/SGT
|
|
|
迅策科技業績環比激增449% 結構性重估或進入千億市值陣營？
Mar 27, 2026 19:12 HKT/SGT
|
|
|
迅策科技业绩环比激增449% 结构性重估或进入千亿市值阵营？
Mar 27, 2026 19:04 HKT/SGT
|
|
|
Analogue 2025 Annual Results Profit Attributable to Owners of the Company Increases 23.5% to HK$167.0 Million
Mar 27, 2026 18:38 HKT/SGT
|
|
|
安樂工程公佈2025年全年業績 本公司擁有人應佔溢利增23.5%至1.670億港元
Mar 27, 2026 18:29 HKT/SGT
|
|
|
安乐工程公布2025年全年业绩 本公司拥有人应占溢利增23.5%至1.670亿港元
Mar 27, 2026 18:18 HKT/SGT
|
|
|
多維驅動全域突破 海天味業2025年交出高品質發展成績單
Mar 27, 2026 18:08 HKT/SGT
|
|
|
多维驱动全局突破 海天味业2025年交出高质量发展成绩单
Mar 27, 2026 17:57 HKT/SGT
|
|
|
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
Mar 27, 2026 18:19 JST
|
|
|
美麗田園2025年報重磅發佈！經調淨利潤大增41% 現金牛實力凸顯
Mar 27, 2026 16:40 HKT/SGT
|
|
|
New "L00 Series" Train for the Seibu Railway's Yamaguchi Line Begins Commercial Operation
Mar 27, 2026 16:51 JST
|
|
|
Modern Dental Group Announces 2025 Annual Results, Net Profit Surges 47.7% on Digitalization-Driven Operational Efficiency Gains
Mar 27, 2026 15:43 HKT/SGT
|
|
|
現代牙科集團公佈2025年全年業績 數碼化驅動運營效率提升 淨利同比大增47.7%
Mar 27, 2026 15:35 HKT/SGT
|
|
|
Thailand Cat Lovers Fair 2026 Returns with Immersive "MEOW LAND" Experience
Mar 27, 2026 15:33 HKT/SGT
|
|
|
现代牙科集团公布2025年全年业绩 数码化驱动运营效率提升 净利同比大增47.7%
Mar 27, 2026 15:25 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
